Pfizer Notches “Milestone” In OTC Switch Plan
This article was originally published in The Tan Sheet
Executive Summary
Nexium 24HR’s is “the first significant milestone” Pfizer’s Rx-to-OTC strategy, says Albert Bourla, head of the division that includes consumer products. The next milestone could be a new drug application for an OTC version of Lipitor.